Skip to main content
TRVI logo

TRVI · Trevi Therapeutics, Inc. · Debt

Track TRVI — free
$12.59 -0.35 (-2.70%)
Market Cap
$1.77B
Shares
142.48M
Volume · Oct 23 716.16K Avg daily vol (3M) 1.97M

Debt Profile

Completed filing coverage through Mar 17, 2026

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-06-30 USD 329,000 10-Q filed 2026-08-06
Noncurrent operating lease liabilities 2026-06-30 USD 276,000 10-Q filed 2026-08-06
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1563880 CUSIP 89532M101 13F (30d) 18 filings 18 filers Visit website Investor relations